Cassano, Paolo
- NYU Grossman School of Medicine · Psychiatry (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #5,164
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2020 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Psychiatry
NIH Funding · FY2023
Linked Award Amount
$1.6M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#5,164
By linked amount among FY2023 PIs
Earliest Year Loaded
2020
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Cassano, Paolo as a PI. Multi-PI records show the full award amount for context.
- 4R33MH122647-03R33Contact PITranscranial Near Infrared Radiation and Cerebral Blood Flow in Depression (TRIADE)NYU Grossman School of Medicine · Psychiatry (NIH department code)$812.9Kaward amount
- 5R01AG068248-04R01Contact PITranscranial Photobiomodulation for Alzheimer's Disease (TRAP-AD)NYU Grossman School of Medicine · Psychiatry (NIH department code)$808.3Kaward amount
Award organization
Organizations that administered FY2023 awards listing Cassano, Paolo as a PI.
FY2023 award administered by NYU Grossman School of Medicine (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2020First NIH AwardNYU Grossman School of Medicine
- 2020$500K Cumulative Funding
- 2020Entered Top 50% NationallyRanked #3737
- 2020Entered Top 25% NationallyRanked #3737
- 2021$1M Cumulative Funding
- 2021$2M Cumulative Funding
- 2021R01 Grant Holder